Evidence map›Paper›PMID 30813301›Full record

ReviewInternational journal of molecular sciences2019

Role of Endoplasmic Reticulum Stress in the Anticancer Activity of Natural Compounds.

Patrizia Limonta, Roberta M Moretti, Monica Marzagalli, Fabrizio Fontana, Michela Raimondi, Marina Montagnani Marelli

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 74 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
74citing papers in PubMed, 2 pooled it
9.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

74 citing papers in PubMed, 2 syntheses or guidelines pooled it, 132 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Review
  5. Article
  6. Review
  7. Review
  8. Review
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Review
  20. Article

14 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Patrizia LimontaDepartment of Pharmacological and Biomolecular Sciences, Università degli Studi di Milano, 20133 Milano, Italy. patrizia.limonta@unimi.it.ORCID 0000-0001-7028-3008
Roberta M MorettiDepartment of Pharmacological and Biomolecular Sciences, Università degli Studi di Milano, 20133 Milano, Italy. roberta.moretti@unimi.it.
Monica MarzagalliDepartment of Pharmacological and Biomolecular Sciences, Università degli Studi di Milano, 20133 Milano, Italy. monica.marzagalli@gmail.com.ORCID 0000-0001-7684-606X
Fabrizio FontanaDepartment of Pharmacological and Biomolecular Sciences, Università degli Studi di Milano, 20133 Milano, Italy. fabrizio.fontana@unimi.it.
Michela RaimondiDepartment of Pharmacological and Biomolecular Sciences, Università degli Studi di Milano, 20133 Milano, Italy. michela.raimondi@unimi.it.ORCID 0000-0002-2965-509X
Marina Montagnani MarelliDepartment of Pharmacological and Biomolecular Sciences, Università degli Studi di Milano, 20133 Milano, Italy. marina.marellimontagnani@unimi.it.ORCID 0000-0002-3739-6278
University of Milan · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cancer represents a serious global health problem, and its incidence and mortality are rapidly growing worldwide. One of the main causes of the failure of an anticancer treatment is the development of drug resistance by cancer cells. Therefore, it is necessary to develop new drugs characterized by better pharmacological and toxicological profiles. Natural compounds can represent an optimal collection of bioactive molecules. Many natural compounds have been proven to possess anticancer effects in different types of tumors, but often the molecular mechanisms associated with their cytotoxicity are not completely understood. The endoplasmic reticulum (ER) is an organelle involved in multiple cellular processes. Alteration of ER homeostasis and its appropriate functioning originates a cascade of signaling events known as ER stress response or unfolded protein response (UPR). The UPR pathways involve three different sensors (protein kinase RNA(PKR)-like ER kinase (PERK), inositol requiring enzyme1α (IRE1) and activating transcription factor 6 (ATF6)) residing on the ER membranes. Although the main purpose of UPR is to restore this organelle's homeostasis, a persistent UPR can trigger cell death pathways such as apoptosis. There is a growing body of evidence showing that ER stress may play a role in the cytotoxicity of many natural compounds. In this review we present an overview of different plant-derived natural compounds, such as curcumin, resveratrol, green tea polyphenols, tocotrienols, and garcinia derivates, that exert their anticancer activity via ER stress modulation in different human cancers.

Indexed as

AnimalsAntineoplastic AgentsApoptosisBiological ProductsEndoplasmic Reticulum StressHumansModels, BiologicalSignal TransductionAntineoplastic AgentsBiological ProductsapoptosiscancerER stressnatural compoundsunfolded protein response

Identifiers

PMID30813301
PMCPMC6412802
OpenAlexW2915111458

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.